Asthika Goonewardene
Stock Analyst at Truist Securities
(1.25)
# 3,512
Out of 4,883 analysts
98
Total ratings
35.23%
Success rate
-13.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Reiterates: Buy | $43 → $55 | $44.06 | +24.83% | 9 | Jun 23, 2025 | |
| IGMS IGM Biosciences | Maintains: Hold | $2 → $1 | $1.36 | -26.50% | 9 | Jun 11, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $111.44 | +39.09% | 2 | Jun 3, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $9 → $10 | $0.31 | +3,120.61% | 4 | May 16, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $37.32 | +90.25% | 2 | May 14, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $14 → $10 | $1.21 | +729.88% | 7 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $2.32 | +331.03% | 4 | Apr 1, 2025 | |
| GMAB Genmab | Maintains: Buy | $50 → $45 | $21.35 | +110.77% | 14 | Mar 11, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $25 → $15 | $1.78 | +742.70% | 6 | Mar 3, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $7 | $4.59 | +52.51% | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.43 | +56.04% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $66.77 | +103.68% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $97 | $112.94 | -14.11% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.75 | +1,896.81% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $8.50 | +417.65% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $88 | $52.42 | +67.87% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.72 | +132.68% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.54 | +1,133.77% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $1.18 | +3,289.83% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.69 | +3,798.92% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $23.17 | +417.91% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.90 | +3,057.89% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $0.47 | +3,071.25% | 4 | Aug 23, 2022 |
Exelixis
Jun 23, 2025
Reiterates: Buy
Price Target: $43 → $55
Current: $44.06
Upside: +24.83%
IGM Biosciences
Jun 11, 2025
Maintains: Hold
Price Target: $2 → $1
Current: $1.36
Upside: -26.50%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $111.44
Upside: +39.09%
Mersana Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $0.31
Upside: +3,120.61%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $37.32
Upside: +90.25%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.21
Upside: +729.88%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.32
Upside: +331.03%
Genmab
Mar 11, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.35
Upside: +110.77%
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $1.78
Upside: +742.70%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $7
Current: $4.59
Upside: +52.51%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $22.43
Upside: +56.04%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $66.77
Upside: +103.68%
Nov 8, 2024
Maintains: Hold
Price Target: $83 → $97
Current: $112.94
Upside: -14.11%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.75
Upside: +1,896.81%
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $8.50
Upside: +417.65%
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $52.42
Upside: +67.87%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.72
Upside: +132.68%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.54
Upside: +1,133.77%
Sep 6, 2023
Reiterates: Buy
Price Target: $40
Current: $1.18
Upside: +3,289.83%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.69
Upside: +3,798.92%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $23.17
Upside: +417.91%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.90
Upside: +3,057.89%
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $0.47
Upside: +3,071.25%